| 000 | 01589 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513235533.0 | ||
| 264 | 0 | _c20010809 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1046/j.1365-2125.2001.01356.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBigoni, R | |
| 245 | 0 | 0 |
_aEffects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cApr 2001 |
||
| 300 |
_a355-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNaloxone _xpharmacology |
| 650 | 0 | 4 |
_aNarcotic Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aOligopeptides _xpharmacology |
| 650 | 0 | 4 |
_aOpioid Peptides _xpharmacology |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Opioid _xagonists |
| 650 | 0 | 4 |
_aVas Deferens _xdrug effects |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 650 | 0 | 4 | _aNociceptin Receptor |
| 650 | 0 | 4 | _aNociceptin |
| 700 | 1 | _aCalo, G | |
| 700 | 1 | _aGuerrini, R | |
| 700 | 1 | _aStrupish, J W | |
| 700 | 1 | _aRowbotham, D J | |
| 700 | 1 | _aLambert, D G | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 51 _gno. 4 _gp. 355-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2125.2001.01356.x _zAvailable from publisher's website |
| 999 |
_c11252978 _d11252978 |
||